Iron Triangle Partners LP — 13F Holdings & Portfolio
CIK 1779763 · latest 13F-HR filed 2026-02-17
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$874.7M
Long-equity book
27
Distinct positions
2025-12-31
Filed 2026-02-17
+16 / −14 / ↑8 / ↓2
vs 2025-09-30
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- CHARLES RIV LABS INTL INC$33.8M +80.6%
- JAZZ PHARMACEUTICALS PLC$29.9M +151.2%
- VERACYTE INC$24.6M +147.9%
- REPLIGEN CORP$16.4M +45.5%
- DOXIMITY INC$15.0M +97.9%
New Positions
- INTUITIVE SURGICAL INC$53.5M
- BOSTON SCIENTIFIC CORP$40.1M
- WATERS CORP$39.9M
- BRUKER CORP$37.4M
- VERTEX PHARMACEUTICALS INC$34.9M
Exited Positions
- DEXCOM INC$57.2M
- ABBVIE INC$46.4M
- MEDTRONIC PLC$43.2M
- GLAUKOS CORP$28.0M
- TENET HEALTHCARE CORP$27.9M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | CHARLES RIV LABS INTL INC | CRL | 159864107 | $75.7M | 8.66% | 379,728 | SH |
| 2 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $53.5M | 6.12% | 94,459 | SH |
| 3 | REPLIGEN CORP | RGEN | 759916109 | $52.5M | 6.00% | 320,474 | SH |
| 4 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $49.7M | 5.68% | 292,170 | SH |
| 5 | VERACYTE INC | VCYT | 92337F107 | $41.3M | 4.72% | 980,391 | SH |
| 6 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $40.1M | 4.59% | 420,773 | SH |
| 7 | WATERS CORP | WAT | 941848103 | $39.9M | 4.57% | 105,167 | SH |
| 8 | BROOKDALE SR LIVING INC | BKD | 112463104 | $37.7M | 4.31% | 3,491,663 | SH |
| 9 | ELI LILLY & CO | LLY | 532457108 | $37.7M | 4.31% | 35,045 | SH |
| 10 | BRUKER CORP | BRKR | 116794108 | $37.4M | 4.28% | 794,380 | SH |
| 11 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $34.9M | 3.99% | 76,910 | SH |
| 12 | CVS HEALTH CORP | CVS | 126650100 | $34.3M | 3.92% | 432,457 | SH |
| 13 | FORTREA HLDGS INC | FTRE | 34965K107 | $34.3M | 3.92% | 1,986,333 | SH |
| 14 | MERIT MED SYS INC | MMSI | 589889104 | $34.0M | 3.89% | 385,660 | SH |
| 15 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $33.6M | 3.84% | 897,427 | SH |
| 16 | DOXIMITY INC | DOCS | 26622P107 | $30.4M | 3.48% | 686,568 | SH |
| 17 | BIO-TECHNE CORP | TECH | 09073M104 | $27.5M | 3.14% | 467,409 | SH |
| 18 | ALPHATEC HLDGS INC | ATEC | 02081G201 | $27.1M | 3.09% | 1,285,685 | SH |
| 19 | ADAPTHEALTH CORP | AHCO | 00653Q102 | $26.0M | 2.97% | 2,609,003 | SH |
| 20 | ENVISTA HOLDINGS CORPORATION | NVST | 29415F104 | $25.8M | 2.95% | 1,186,704 | SH |
| 21 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $23.1M | 2.65% | 70,126 | SH |
| 22 | ABBOTT LABS | ABT | 002824100 | $22.0M | 2.51% | 175,333 | SH |
| 23 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $16.2M | 1.85% | 467,484 | SH |
| 24 | BIOHAVEN LTD | BHVN | G1110E107 | $10.8M | 1.24% | 958,336 | SH |
| 25 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $10.5M | 1.20% | 233,688 | SH |
| 26 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $9.5M | 1.09% | 230,730 | SH |
| 27 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $9.3M | 1.07% | 257,085 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2025-12-31 | 2026-02-17 | $874.7M | 27 | 0001172661-26-000928 |
| 2025-09-30 | 2025-11-14 | $703.3M | 25 | 0001172661-25-004856 |